{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T04:05:58Z","timestamp":1792037158554,"version":"4.4.0"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11926-025-01187-8","type":"journal-article","created":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T02:06:46Z","timestamp":1743300406000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Gout, Hyperuricemia and Psoriatic Arthritis: An Evolving Conundrum"],"prefix":"10.1007","volume":"27","author":[{"given":"Priyanka","family":"Chandratre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Sabido-Sauri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sizheng Steven","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Abhishek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,27]]},"reference":[{"issue":"4","key":"1187_CR1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.9501","volume":"6","author":"C Yokose","year":"2023","unstructured":"Yokose C, McCormick N, Lu N, Tanikella S, Lin K, Joshi AD, et al. Trends in Prevalence of Gout Among US Asian Adults, 2011\u20132018. JAMA Netw Open. 2023;6(4): e239501.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"1187_CR2","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jbspin.2014.07.002","volume":"82","author":"FY Tu","year":"2015","unstructured":"Tu FY, Lin GT, Lee SS, Tung YC, Tu HP, Chiang HC. Prevalence of gout with comorbidity aggregations in southern Taiwan. Joint Bone Spine. 2015;82(1):45\u201351.","journal-title":"Joint Bone Spine"},{"issue":"5","key":"1187_CR3","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1093\/rheumatology\/ker361","volume":"51","author":"D Winnard","year":"2012","unstructured":"Winnard D, Wright C, Taylor WJ, Jackson G, Te Karu L, Gow PJ, et al. National prevalence of gout derived from administrative health data in Aotearoa New Zealand. Rheumatology. 2012;51(5):901\u20139.","journal-title":"Rheumatology"},{"issue":"4","key":"1187_CR4","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.semarthrit.2016.08.006","volume":"46","author":"SK Rai","year":"2017","unstructured":"Rai SK, Avi\u00f1a-Zubieta JA, McCormick N, De Vera MA, Shojania K, Sayre EC, et al. The rising prevalence and incidence of gout in British Columbia, Canada: Population-based trends from 2000 to 2012. Semin Arthritis Rheum. 2017;46(4):451\u20136.","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"1187_CR5","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1136\/annrheumdis-2021-221989","volume":"81","author":"A Abhishek","year":"2022","unstructured":"Abhishek A, Tata LJ, Mamas M, Avery AJ. Has the gout epidemic peaked in the UK? A nationwide cohort study using data from the Clinical Practice Research Datalink, from 1997 to across the COVID-19 pandemic in 2021. Ann Rheum Dis. 2022;81(6):898\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1187_CR6","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s13075-016-1062-6","volume":"18","author":"M Dehlin","year":"2016","unstructured":"Dehlin M, Drivelegka P, Sigurdardottir V, Sv\u00e4rd A, Jacobsson LTH. Incidence and prevalence of gout in Western Sweden. Arthritis Res Ther. 2016;18(1):164.","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"1187_CR7","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/art.1780150209","volume":"15","author":"JN Loeb","year":"1972","unstructured":"Loeb JN. The influence of temperature on the solubility of monosodium urate. Arthritis Rheum. 1972;15(2):189\u201392.","journal-title":"Arthritis Rheum"},{"issue":"11","key":"1187_CR8","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1002\/art.40572","volume":"70","author":"A Abhishek","year":"2018","unstructured":"Abhishek A, Courtney P, Jenkins W, Sandoval-Plata G, Jones AC, Zhang W, et al. Brief report: monosodium urate monohydrate crystal deposits are common in asymptomatic sons of patients with gout: the sons of gout study. Arthritis Rheumatol. 2018;70(11):1847\u201352.","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"1187_CR9","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3899\/jrheum.160452","volume":"44","author":"A Shiozawa","year":"2017","unstructured":"Shiozawa A, Szabo SM, Bolzani A, Cheung A, Choi HK. Serum uric acid and the risk of incident and recurrent gout: A systematic review. J Rheumatol. 2017;44(3):388\u201396.","journal-title":"J Rheumatol"},{"issue":"4","key":"1187_CR10","doi-asserted-by":"publisher","first-page":"258","DOI":"10.7547\/1000258","volume":"100","author":"RA Nardin","year":"2010","unstructured":"Nardin RA, Fogerson PM, Nie R, Rutkove SB. Foot temperature in healthy individuals: effects of ambient temperature and age. J Am Podiatr Med Assoc. 2010;100(4):258.","journal-title":"J Am Podiatr Med Assoc"},{"issue":"4","key":"1187_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2021.101717","volume":"35","author":"VL Halperin Kuhns","year":"2021","unstructured":"Halperin Kuhns VL, Woodward OM. Urate transport in health and disease. Best Pract Res Clin Rheumatol. 2021;35(4): 101717.","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"7","key":"1187_CR12","doi-asserted-by":"publisher","first-page":"499","DOI":"10.7326\/0003-4819-143-7-200510040-00009","volume":"143","author":"HK Choi","year":"2005","unstructured":"Choi HK, Mount DB, Reginato AM. Pathogenesis of gout. Ann Intern Med. 2005;143(7):499\u2013516.","journal-title":"Ann Intern Med"},{"issue":"3","key":"1187_CR13","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1136\/ard.51.3.375","volume":"51","author":"BT Emmerson","year":"1992","unstructured":"Emmerson BT, Nagel SL, Duffy DL, Martin NG. Genetic control of the renal clearance of urate: a study of twins. Ann Rheum Dis. 1992;51(3):375\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"1187_CR14","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1038\/s41588-019-0504-x","volume":"51","author":"A Tin","year":"2019","unstructured":"German Chronic Kidney Disease Study, Lifelines Cohort Study, V. A. Million Veteran Program, Tin A, Marten J, Halperin Kuhns VL, et al. Target genes, variants, tissues and transcriptional pathways influencing human serum urate levels. Nat Genet. 2019;51(10):1459\u201374.","journal-title":"Nat Genet"},{"issue":"10","key":"1187_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.xgen.2022.100192","volume":"2","author":"W Zhou","year":"2022","unstructured":"Zhou W, Kanai M, Wu KHH, Rasheed H, Tsuo K, Hirbo JB, et al. Global Biobank Meta-analysis Initiative: Powering genetic discovery across human disease. Cell Genomics. 2022Oct;2(10): 100192.","journal-title":"Cell Genomics"},{"issue":"9","key":"1187_CR16","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1136\/annrheumdis-2020-219796","volume":"80","author":"G Sandoval-Plata","year":"2021","unstructured":"Sandoval-Plata G, Morgan K, Abhishek A. Variants in urate transporters, ADH1B, GCKR and MEPE genes associate with transition from asymptomatic hyperuricaemia to gout: results of the first gout versus asymptomatic hyperuricaemia GWAS in Caucasians using data from the UK Biobank. Ann Rheum Dis. 2021;80(9):1220\u20136.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"1187_CR17","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1136\/annrheumdis-2014-206397","volume":"74","author":"N Dalbeth","year":"2015","unstructured":"Dalbeth N, House ME, Aati O, Tan P, Franklin C, Horne A, et al. Urate crystal deposition in asymptomatic hyperuricaemia and symptomatic gout: a dual energy CT study. Ann Rheum Dis. 2015;74(5):908\u201311.","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"1187_CR18","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1136\/ard.2006.055251","volume":"65","author":"W Zhang","year":"2006","unstructured":"Zhang W. EULAR evidence-based recommendations for gout. Part I: Diagnosis. Report of a task force of the standing committee for international clinical studies including therapeutics (ESCISIT). Ann Rheum Dis. 2006;65(10):1301\u201311.","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"1187_CR19","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1136\/ard.2006.063768","volume":"66","author":"E Roddy","year":"2007","unstructured":"Roddy E, Zhang W, Doherty M. Are joints affected by gout also affected by osteoarthritis? Ann Rheum Dis. 2007;66(10):1374\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"7081","key":"1187_CR20","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nature04516","volume":"440","author":"F Martinon","year":"2006","unstructured":"Martinon F, P\u00e9trilli V, Mayor A, Tardivel A, Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature. 2006;440(7081):237\u201341.","journal-title":"Nature"},{"issue":"5","key":"1187_CR21","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/nm.3547","volume":"20","author":"C Schauer","year":"2014","unstructured":"Schauer C, Janko C, Munoz LE, Zhao Y, Kienh\u00f6fer D, Frey B, et al. Aggregated neutrophil extracellular traps limit inflammation by degrading cytokines and chemokines. Nat Med. 2014;20(5):511\u20137.","journal-title":"Nat Med"},{"key":"1187_CR22","doi-asserted-by":"crossref","unstructured":"Mease PJ, Karki C, Palmer JB, Etzel CJ, Kavanaugh A, Ritchlin CT, et al. Clinical characteristics, patients with dactylitis or enthesitis: results from the corrona psoriatic arthritis\/spondyloarthritis registry. Arthritis Care Res. 2017;69(11):1692\u20139.","DOI":"10.1002\/acr.23249"},{"issue":"2","key":"1187_CR23","first-page":"101","volume":"36","author":"YG Tsai","year":"2003","unstructured":"Tsai YG, Chang DM, Kuo SY, Wang WM, Chen YC, Lai JH. Relationship between human lymphocyte antigen-B27 and clinical features of psoriatic arthritis. J Microbiol Immunol Infect Wei Mian Yu Gan Ran Za Zhi. 2003;36(2):101\u20134.","journal-title":"J Microbiol Immunol Infect Wei Mian Yu Gan Ran Za Zhi"},{"issue":"supp_2","key":"1187_CR24","doi-asserted-by":"publisher","first-page":"ii55","DOI":"10.1136\/ard.2004.033928","volume":"64","author":"PA Ory","year":"2005","unstructured":"Ory PA. Psoriatic arthritis and imaging. Ann Rheum Dis. 2005;64(supp_2):ii55-7.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"1187_CR25","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1007\/s10067-020-04981-0","volume":"39","author":"R Felten","year":"2020","unstructured":"Felten R, Duret PM, Gottenberg JE, Spielmann L, Messer L. At the crossroads of gout and psoriatic arthritis: \u201cpsout.\u201d Clin Rheumatol. 2020;39(5):1405\u201313.","journal-title":"Clin Rheumatol"},{"issue":"8","key":"1187_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.737573","volume":"22","author":"C Tripolino","year":"2021","unstructured":"Tripolino C, Ciaffi J, Ruscitti P, Giacomelli R, Meliconi R, Ursini F. Hyperuricemia in psoriatic arthritis: epidemiology, pathophysiology, and clinical implications. Front Med. 2021;22(8): 737573.","journal-title":"Front Med"},{"issue":"9","key":"1187_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7573\/dic.2020-2-1","volume":"21","author":"KA Fieldhouse","year":"2020","unstructured":"Fieldhouse KA, Ukaibe S, Crowley EL, Khanna R, O\u2019Toole A, Gooderham MJ. Inflammatory bowel disease in patients with psoriasis treated with interleukin-17 inhibitors. Drugs Context. 2020;21(9):1\u20139.","journal-title":"Drugs Context"},{"key":"1187_CR28","unstructured":"Gossec L, Kerschbaumer A, Ferreira RJO, Aletaha D, Baraliakos X, Bertheussen H, et al. EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update. Ann Rheum Dis. 2024 Mar 18;ard-2024\u2013225531."},{"issue":"6","key":"1187_CR29","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1002\/acr.24180","volume":"72","author":"JD FitzGerald","year":"2020","unstructured":"FitzGerald JD, Dalbeth N, Mikuls T, Brignardello-Petersen R, Guyatt G, Abeles AM, et al. American college of rheumatology guideline for the management of gout. Arthritis Care Res. 2020;72(6):744\u201360.","journal-title":"Arthritis Care Res"},{"issue":"682","key":"1187_CR30","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1136\/pgmj.58.682.477","volume":"58","author":"JN Fordham","year":"1982","unstructured":"Fordham JN, Storey GO. Psoriasis and gout. Postgrad Med J. 1982;58(682):477\u201380.","journal-title":"Postgrad Med J"},{"issue":"5","key":"1187_CR31","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/j.1365-2230.2010.03988.x","volume":"36","author":"HH Kwon","year":"2011","unstructured":"Kwon HH, Kwon IH, Choi JW, Youn JI. Cross-sectional study on the correlation of serum uric acid with disease severity in Korean patients with psoriasis. Clin Exp Dermatol. 2011;36(5):473\u20138.","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"1187_CR32","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jaad.2013.09.005","volume":"70","author":"P Gisondi","year":"2014","unstructured":"Gisondi P, Targher G, Cagalli A, Girolomoni G. Hyperuricemia in patients with chronic plaque psoriasis. J Am Acad Dermatol. 2014;70(1):127\u201330.","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"1187_CR33","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1136\/annrheumdis-2014-205212","volume":"74","author":"JF Merola","year":"2015","unstructured":"Merola JF, Wu S, Han J, Choi HK, Qureshi AA. Psoriasis, psoriatic arthritis and risk of gout in US men and women. Ann Rheum Dis. 2015;74(8):1495\u2013500.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1187_CR34","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/rheumatology\/kes169","volume":"52","author":"CF Kuo","year":"2013","unstructured":"Kuo CF, Yu KH, See LC, Chou IJ, Ko YS, Chang HC, et al. Risk of myocardial infarction among patients with gout: a nationwide population-based study. Rheumatology. 2013;52(1):111\u20137.","journal-title":"Rheumatology"},{"issue":"3","key":"1187_CR35","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1111\/bjd.15149","volume":"176","author":"KF Hjuler","year":"2017","unstructured":"Hjuler KF, Gormsen LC, Vendelbo MH, Egeberg A, Nielsen J, Iversen L. Increased global arterial and subcutaneous adipose tissue inflammation in patients with moderate-to-severe psoriasis. Br J Dermatol. 2017;176(3):732\u201340.","journal-title":"Br J Dermatol"},{"key":"1187_CR36","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1007\/s00296-024-05729-8","volume":"44","author":"A Sherri","year":"2024","unstructured":"Sherri A, Mortada MM, Makowska J, et al. Understanding the interplay between psoriatic arthritis and gout: \u201cPsout.\u201d Rheumatol Int. 2024;44:2699\u2013709.","journal-title":"Rheumatol Int"},{"issue":"3","key":"1187_CR37","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1111\/jdv.15290","volume":"33","author":"SC-S Hu","year":"2019","unstructured":"Hu SC-S, Lin C-L, Tu H-P. Association between psoriasis, psoriatic arthritis and gout: a nationwide population-based study. J Eur Acad Dermatol Venereol. 2019;33(3):560\u20137.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"11","key":"1187_CR38","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1056\/NEJMoa035700","volume":"350","author":"HK Choi","year":"2004","unstructured":"Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G. Purine-Rich Foods, Dairy and Protein Intake, and the Risk of Gout in Men. N Engl J Med. 2004;350(11):1093\u2013103.","journal-title":"N Engl J Med"},{"issue":"4","key":"1187_CR39","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1111\/1756-185X.13265","volume":"21","author":"TL Lai","year":"2018","unstructured":"Lai TL, Yim CW, Wong PY, Leung MC, Ng WL. Hyperuricemia in Asian psoriatic arthritis patients. Int J Rheum Dis. 2018;21(4):843\u20139.","journal-title":"Int J Rheum Dis"},{"issue":"5","key":"1187_CR40","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/jid.1958.119","volume":"31","author":"WA Lea","year":"1958","unstructured":"Lea WA, Curtis AC, Bernstein IA. Serum Uric Acid Levels in Psoriasis. J Invest Dermatol. 1958;31(5):269\u201371.","journal-title":"J Invest Dermatol"},{"issue":"19","key":"1187_CR41","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003676","volume":"95","author":"X Li","year":"2016","unstructured":"Li X, Miao X, Wang H, Wang Y, Li F, Yang Q, et al. Association of Serum Uric Acid Levels in Psoriasis: A Systematic Review and Meta-Analysis. Medicine (Baltimore). 2016;95(19): e3676.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"1187_CR42","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1097\/00124743-200002000-00001","volume":"6","author":"IN Bruce","year":"2000","unstructured":"Bruce IN, Schentag CT, Gladman DD. Hyperuricemia in psoriatic arthritis: prevalence and associated features. J Clin Rheumatol. 2000;6(1):6\u20139.","journal-title":"J Clin Rheumatol"},{"issue":"3","key":"1187_CR43","doi-asserted-by":"publisher","first-page":"J314","DOI":"10.1016\/j.jaut.2009.12.001","volume":"34","author":"V Chandran","year":"2010","unstructured":"Chandran V, Raychaudhuri SP. Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis. J Autoimmun. 2010;34(3):J314\u201321.","journal-title":"J Autoimmun"},{"issue":"2","key":"1187_CR44","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/jid.2012.434","volume":"133","author":"M Enamandram","year":"2013","unstructured":"Enamandram M, Kimball AB. Psoriasis epidemiology: the interplay of genes and the environment. J Invest Dermatol. 2013;133(2):287\u20139.","journal-title":"J Invest Dermatol"},{"issue":"12","key":"1187_CR45","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1111\/1346-8138.13968","volume":"44","author":"N Tsuruta","year":"2017","unstructured":"Tsuruta N, Imafuku S, Narisawa Y. Hyperuricemia is an independent risk factor for psoriatic arthritis in psoriatic patients. J Dermatol. 2017;44(12):1349\u201352.","journal-title":"J Dermatol"},{"issue":"21","key":"1187_CR46","doi-asserted-by":"publisher","first-page":"3004","DOI":"10.1001\/jama.1991.03470210072035","volume":"266","author":"R Roubenoff","year":"1991","unstructured":"Roubenoff R, Klag MJ, Mead LA, Liang KY, Seidler AJ, Hochberg MC. Incidence and risk factors for gout in white men. JAMA J Am Med Assoc. 1991;266(21):3004\u20137.","journal-title":"JAMA J Am Med Assoc"},{"issue":"7","key":"1187_CR47","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.amjmed.2011.09.033","volume":"125","author":"Y Zhu","year":"2012","unstructured":"Zhu Y, Pandya BJ, Choi HK. Comorbidities of Gout and Hyperuricemia in the US General Population: NHANES 2007\u20132008. Am J Med. 2012;125(7):679-687.e1.","journal-title":"Am J Med"},{"issue":"4","key":"1187_CR48","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1111\/j.1365-2133.2009.09247.x","volume":"161","author":"PL Dominguez","year":"2009","unstructured":"Dominguez PL, Assarpour A, Kuo H, Holt EW, Tyler S, Qureshi AA. Development and pilot-testing of a psoriasis screening tool. Br J Dermatol. 2009;161(4):778\u201384.","journal-title":"Br J Dermatol"},{"issue":"3","key":"1187_CR49","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1002\/art.1780200320","volume":"20","author":"SL Wallace","year":"1977","unstructured":"Wallace SL, Robinson H, Masi AT, Decker JL, Mccarty DJ, Y\u00fc TF. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum. 1977;20(3):895\u2013900.","journal-title":"Arthritis Rheum"},{"issue":"8","key":"1187_CR50","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1007\/s00296-023-05322-5","volume":"43","author":"Y Ross","year":"2023","unstructured":"Ross Y, Jaleel S, Magrey M. Racial disparities in comorbidities of patients with psoriatic arthritis. Rheumatol Int. 2023;43(8):1525\u20139.","journal-title":"Rheumatol Int"},{"issue":"12","key":"1187_CR51","doi-asserted-by":"publisher","first-page":"3677","DOI":"10.1007\/s10067-020-05132-1","volume":"39","author":"YJ Su","year":"2020","unstructured":"Su YJ. Early diagnosis of psoriatic arthritis among psoriasis patients: clinical experience sharing. Clin Rheumatol. 2020;39(12):3677\u201384.","journal-title":"Clin Rheumatol"},{"issue":"1","key":"1187_CR52","first-page":"122","volume":"25","author":"J Kaine","year":"2019","unstructured":"Kaine J, Song X, Kim G, Hur P, Palmer JB. Higher incidence rates of comorbidities in patients with psoriatic arthritis compared with the general population using U.S. administrative claims data. J Manag Care Spec Pharm. 2019;25(1):122\u201332.","journal-title":"J Manag Care Spec Pharm"},{"issue":"14","key":"1187_CR53","doi-asserted-by":"publisher","first-page":"265","DOI":"10.2147\/CLEP.S346128","volume":"8","author":"JC Wei","year":"2022","unstructured":"Wei JC, Chang YJ, Wang YH, Yeh CJ. The risk of gout in patients with psoriasis: a population-based cohort study in Taiwan. Clin Epidemiol. 2022;8(14):265\u201373. https:\/\/doi.org\/10.2147\/CLEP.S346128.","journal-title":"Clin Epidemiol"},{"issue":"2","key":"1187_CR54","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3899\/jrheum.170384","volume":"45","author":"R AlJohani","year":"2018","unstructured":"AlJohani R, Polachek A, Ye JY, Chandran V, Gladman DD. Characteristic and outcome of psoriatic arthritis patients with hyperuricemia. J Rheumatol. 2018;45(2):213\u20137.","journal-title":"J Rheumatol"},{"issue":"3","key":"1187_CR55","doi-asserted-by":"publisher","first-page":"rkae069","DOI":"10.1093\/rap\/rkae069","volume":"8","author":"V Moukarzel","year":"2024","unstructured":"Moukarzel V, Doussi\u00e8re M, Barbier V, Menis J, Le Monnier L, Salomon-Go\u00ebb S, Aboudiab M, Go\u00ebb V. Interest in daily clinical practice of screening for gouty disease in patients with psoriatic arthritis. Rheumatol Adv Pract. 2024;8(3):rkae069. https:\/\/doi.org\/10.1093\/rap\/rkae069.","journal-title":"Rheumatol Adv Pract"},{"issue":"3","key":"1187_CR56","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.jbspin.2012.08.006","volume":"80","author":"F Oliviero","year":"2013","unstructured":"Oliviero F, Scanu A, Galozzi P, Gava A, Frallonardo P, Ramonda R, et al. Prevalence of calcium pyrophosphate and monosodium urate crystals in synovial fluid of patients with previously diagnosed joint diseases. Joint Bone Spine. 2013;80(3):287\u201390.","journal-title":"Joint Bone Spine"},{"issue":"6","key":"1187_CR57","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1002\/art.40807","volume":"71","author":"M Chen-Xu","year":"2019","unstructured":"Chen-Xu M, Yokose C, Rai SK, Pillinger MH, Choi HK. Contemporary prevalence of gout and hyperuricemia in the united states and decadal trends: the national health and nutrition examination survey, 2007\u20132016. Arthritis Rheumatol. 2019;71(6):991\u20139.","journal-title":"Arthritis Rheumatol"},{"issue":"18","key":"1187_CR58","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1177\/15353702221110666","volume":"247","author":"P Galozzi","year":"2022","unstructured":"Galozzi P, Oliviero F, Scanu A, Lorenzin M, Ortolan A, Favero M, et al. Acute joint swelling in psoriatic arthritis: Flare or \u201cpsout\u201d\u2014A 10-year-monocentric study on synovial fluid. Exp Biol Med. 2022;247(18):1650\u20136.","journal-title":"Exp Biol Med"},{"issue":"2","key":"1187_CR59","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/art.1780340203","volume":"34","author":"E Pascual","year":"1991","unstructured":"Pascual E. Persistence of monosodium urate crystals and low-grade inflammation in the synovial fluid of patients with untreated gout. Arthritis Rheum. 1991;34(2):141\u20135.","journal-title":"Arthritis Rheum"},{"key":"1187_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2020.108397","volume":"214","author":"LM Perez-Chada","year":"2020","unstructured":"Perez-Chada LM, Merola JF. Comorbidities associated with psoriatic arthritis: Review and update. Clin Immunol. 2020;214: 108397.","journal-title":"Clin Immunol"},{"issue":"8","key":"1187_CR61","doi-asserted-by":"publisher","first-page":"775.e1","DOI":"10.1016\/j.amjmed.2011.03.028","volume":"124","author":"NN Mehta","year":"2011","unstructured":"Mehta NN, Yu Y, Pinnelas R, Krishnamoorthy P, Shin DB, Troxel AB, et al. Attributable risk estimate of severe psoriasis on major cardiovascular events. Am J Med. 2011;124(8):775.e1-775.e6.","journal-title":"Am J Med"},{"issue":"5","key":"1187_CR62","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1080\/030097401753180345","volume":"30","author":"Alenius","year":"2001","unstructured":"Alenius, Stegmayr BG, Solbrit GM. Renal abnormalities in a population of patients with psoriatic arthritis. Scand J Rheumatol. 2001;30(5):271\u20134.","journal-title":"Scand J Rheumatol"},{"issue":"3","key":"1187_CR63","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1177\/2047487313514895","volume":"22","author":"L Clarson","year":"2015","unstructured":"Clarson L, Chandratre P, Hider S, Belcher J, Heneghan C, Roddy E, et al. Increased cardiovascular mortality associated with gout: a systematic review and meta-analysis. Eur J Prev Cardiol. 2015;22(3):335\u201343.","journal-title":"Eur J Prev Cardiol"},{"issue":"3","key":"1187_CR64","doi-asserted-by":"publisher","first-page":"238","DOI":"10.2174\/1573403X11666141122220003","volume":"11","author":"G Graham","year":"2015","unstructured":"Graham G. Disparities in cardiovascular disease risk in the united states. Curr Cardiol Rev. 2015;11(3):238\u201345.","journal-title":"Curr Cardiol Rev"},{"issue":"12","key":"1187_CR65","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.703119","volume":"15","author":"Z Chen","year":"2021","unstructured":"Chen Z, Xu Y, Chen M, Cui R, Wang YH, Dai SM, et al. Gout augments the risk of cardiovascular disease in patients with psoriasis: a population-based cohort study. Front Immunol. 2021;15(12): 703119.","journal-title":"Front Immunol"},{"issue":"7","key":"1187_CR66","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1093\/oxfordjournals.aje.a117479","volume":"141","author":"DS Freedman","year":"1995","unstructured":"Freedman DS, Williamson DF, Gunter EW, Byers T. Relation of serum uric acid to mortality and ischemic heart disease. Am J Epidemiol. 1995;141(7):637\u201344.","journal-title":"Am J Epidemiol"},{"issue":"11","key":"1187_CR67","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.1681\/ASN.2014070660","volume":"26","author":"ME Kleber","year":"2015","unstructured":"Kleber ME, Delgado G, Grammer TB, Silbernagel G, Huang J, Kr\u00e4mer BK, et al. Uric acid and cardiovascular events: a mendelian randomization study. J Am Soc Nephrol. 2015;26(11):2831\u20138.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"1187_CR68","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s12291-011-0132-4","volume":"26","author":"JVK Isha","year":"2011","unstructured":"Isha JVK, Lal H. C-Reactive Protein and Uric Acid Levels in Patients with Psoriasis. Indian J Clin Biochem. 2011;26(3):309\u201311.","journal-title":"Indian J Clin Biochem"},{"issue":"2","key":"1187_CR69","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.amjcard.2009.03.017","volume":"104","author":"Y Brodov","year":"2009","unstructured":"Brodov Y, Behar S, Goldenberg I, Boyko V, Chouraqui P. Usefulness of combining serum uric acid and C-reactive protein for risk stratification of patients with coronary artery disease (Bezafibrate Infarction Prevention [BIP] Study). Am J Cardiol. 2009;104(2):194\u20138.","journal-title":"Am J Cardiol"},{"issue":"7","key":"1187_CR70","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1001\/jamadermatol.2015.6262","volume":"152","author":"AS L\u00f8nnberg","year":"2016","unstructured":"L\u00f8nnberg AS, Skov L, Skytthe A, Kyvik KO, Pedersen OB, Thomsen SF. Association of psoriasis with the risk for type 2 diabetes mellitus and obesity. JAMA Dermatol. 2016;152(7):761\u20137.","journal-title":"JAMA Dermatol"},{"issue":"8","key":"1187_CR71","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.3899\/jrheum.121500","volume":"40","author":"JA Husted","year":"2013","unstructured":"Husted JA, Thavaneswaran A, Chandran V, Gladman DD. Incremental effects of comorbidity on quality of life in patients with psoriatic arthritis. J Rheumatol. 2013;40(8):1349\u201356.","journal-title":"J Rheumatol"},{"issue":"11","key":"1187_CR72","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1093\/rheumatology\/ket265","volume":"52","author":"P Chandratre","year":"2013","unstructured":"Chandratre P, Roddy E, Clarson L, Richardson J, Hider SL, Mallen CD. Health-related quality of life in gout: a systematic review. Rheumatology. 2013;52(11):2031\u201340.","journal-title":"Rheumatology"},{"issue":"5","key":"1187_CR73","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1080\/03009742.2022.2157962","volume":"52","author":"A Landgren","year":"2023","unstructured":"Landgren A, Klingberg E, Jacobsson L, Bergsten U, Dehlin M. Health-related quality of life in gout, psoriatic arthritis, rheumatoid arthritis and ankylosing spondylitis, results from a cross-sectional survey in Western Sweden. Scand J Rheumatol. 2023;52(5):506\u201318.","journal-title":"Scand J Rheumatol"},{"issue":"3","key":"1187_CR74","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s11926-996-0030-6","volume":"8","author":"A Gentili","year":"2006","unstructured":"Gentili A. The advanced imaging of gouty tophi. Curr Rheumatol Rep. 2006;8(3):231\u20135.","journal-title":"Curr Rheumatol Rep"},{"issue":"13","key":"1187_CR75","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000676","volume":"94","author":"S Dhaese","year":"2015","unstructured":"Dhaese S, Stryckers M, Van Der Meersch H, Terryn W, Van Laecke S. Gouty arthritis of the spine in a renal transplant patient: a clinical case report an unusual presentation of a common disorder. Medicine (Baltimore). 2015;94(13): e676.","journal-title":"Medicine (Baltimore)"},{"issue":"8","key":"1187_CR76","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.3899\/jrheum.121433","volume":"40","author":"A Haddad","year":"2013","unstructured":"Haddad A, Thavaneswaran A, Toloza S, Chandran V, Gladman DD. Diffuse idiopathic skeletal hyperostosis in psoriatic arthritis. J Rheumatol. 2013;40(8):1367\u201373.","journal-title":"J Rheumatol"},{"issue":"1","key":"1187_CR77","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1136\/ard.2011.154997","volume":"71","author":"E De Miguel","year":"2012","unstructured":"De Miguel E, Puig JG, Castillo C, Peiteado D, Torres RJ, Mart\u00edn-Mola E. Diagnosis of gout in patients with asymptomatic hyperuricaemia: a pilot ultrasound study: Table 1. Ann Rheum Dis. 2012;71(1):157\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1187_CR78","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13047-017-0203-8","volume":"10","author":"S Stewart","year":"2017","unstructured":"Stewart S, Dalbeth N, Vandal AC, Allen B, Miranda R, Rome K. Are ultrasound features at the first metatarsophalangeal joint associated with clinically-assessed pain and function? A study of people with gout, asymptomatic hyperuricaemia and normouricaemia. J Foot Ankle Res. 2017;10(1):22.","journal-title":"J Foot Ankle Res"},{"issue":"12","key":"1187_CR79","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1111\/1756-185X.12938","volume":"19","author":"GS Breuer","year":"2016","unstructured":"Breuer GS, Bogot N, Nesher G. Dual-energy computed tomography as a diagnostic tool for gout during intercritical periods. Int J Rheum Dis. 2016;19(12):1337\u201341.","journal-title":"Int J Rheum Dis"},{"issue":"1","key":"1187_CR80","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2017-000593","volume":"4","author":"P Wang","year":"2018","unstructured":"Wang P, Smith SE, Garg R, Lu F, Wohlfahrt A, Campos A, et al. Identification of monosodium urate crystal deposits in patients with asymptomatic hyperuricemia using dual-energy CT. RMD Open. 2018;4(1): e000593.","journal-title":"RMD Open"},{"issue":"11","key":"1187_CR81","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1136\/annrheumdis-2020-217392","volume":"79","author":"HB Hammer","year":"2020","unstructured":"Hammer HB, Karoliussen L, Terslev L, Haavardsholm EA, Kvien TK, Uhlig T. Ultrasound shows rapid reduction of crystal depositions during a treat-to-target approach in gout patients: 12-month results from the NOR-Gout study. Ann Rheum Dis. 2020;79(11):1500\u20135.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"1187_CR82","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.clinimag.2014.12.015","volume":"39","author":"HJ Hu","year":"2015","unstructured":"Hu HJ, Liao MY, Xu LY. Clinical utility of dual-energy CT for gout diagnosis. Clin Imaging. 2015;39(5):880\u20135.","journal-title":"Clin Imaging"},{"issue":"6","key":"1187_CR83","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1136\/ard-2023-224771","volume":"83","author":"P Mandl","year":"2024","unstructured":"Mandl P, D\u2019Agostino MA, Navarro-Comp\u00e1n V, Ge\u00dfl I, Sakellariou G, Abhishek A, et al. 2023 EULAR recommendations on imaging in diagnosis and management of crystal-induced arthropathies in clinical practice. Ann Rheum Dis. 2024;83(6):752\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"1187_CR84","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1007\/s10067-022-06061-x","volume":"41","author":"L Widawski","year":"2022","unstructured":"Widawski L, Fabacher T, Spielmann L, Gottenberg JE, Sibilia J, Duret PM, et al. Psoriatic arthritis with hyperuricemia: more peripheral, destructive, and challenging to treat. Clin Rheumatol. 2022;41(5):1421\u20139.","journal-title":"Clin Rheumatol"},{"issue":"2014","key":"1187_CR85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/852954","volume":"16","author":"L Billiet","year":"2014","unstructured":"Billiet L, Doaty S, Katz JD, Velasquez MT. Review of hyperuricemia as new marker for metabolic syndrome. ISRN Rheumatol. 2014;16(2014):1\u20137.","journal-title":"ISRN Rheumatol"},{"issue":"3","key":"1187_CR86","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1111\/jdv.16004","volume":"34","author":"S Gerdes","year":"2020","unstructured":"Gerdes S, Pinter A, Papavassilis C, Reinhardt M. Effects of secukinumab on metabolic and liver parameters in plaque psoriasis patients. J Eur Acad Dermatol Venereol. 2020;34(3):533\u201341.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1187_CR87","doi-asserted-by":"publisher","first-page":"153","DOI":"10.2147\/PTT.S486152","volume":"14","author":"C Wu","year":"2024","unstructured":"Wu C, He C, Wang H, Wang W, Jin H. Impact of IL-17A inhibitors on serum uric acid levels in psoriatic patients with hyperuricemia: a prospective observational study. Psoriasis Targets Therapy. 2024;14:153\u201366. https:\/\/doi.org\/10.2147\/PTT.S486152.","journal-title":"Psoriasis Targets Therapy"},{"issue":"1","key":"1187_CR88","doi-asserted-by":"publisher","first-page":"rkab009","DOI":"10.1093\/rap\/rkab009","volume":"5","author":"M Dehlin","year":"2021","unstructured":"Dehlin M, Fasth AER, Reinhardt M, Jacobsson LTH. Impact of psoriasis disease activity and other risk factors on serum urate levels in patients with psoriasis and psoriatic arthritis\u2014a post-hoc analysis of pooled data from three phase 3 trials with secukinumab. Rheumatol Adv Pract. 2021;5(1):rkab009.","journal-title":"Rheumatol Adv Pract"},{"issue":"10","key":"1187_CR89","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1007\/s00296-019-04394-6","volume":"39","author":"L Hasikova","year":"2019","unstructured":"Hasikova L, Pavlikova M, Hulejova H, Kozlik P, Kalikova K, Mahajan A, et al. Serum uric acid increases in patients with systemic autoimmune rheumatic diseases after 3 months of treatment with TNF inhibitors. Rheumatol Int. 2019;39(10):1749\u201357.","journal-title":"Rheumatol Int"},{"issue":"9","key":"1187_CR90","first-page":"1950","volume":"29","author":"W Urano","year":"2002","unstructured":"Urano W, Yamanka H, Tsutani H, Nakajima H, Matsuda Y, Taniguchi A, et al. The inflammatory process in the mechanism of decreased serum uric acid concentrations during acute gouty arthritis. J Rheumatol. 2002;29(9):1950\u20133.","journal-title":"J Rheumatol."},{"issue":"1","key":"1187_CR91","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1093\/rheumatology\/keaa425","volume":"60","author":"D Luis-Rodr\u00edguez","year":"2021","unstructured":"Luis-Rodr\u00edguez D, Donate-Correa J, Mart\u00edn-N\u00fa\u00f1ez E, Ferri C, Tagua VG, P\u00e9rez Castro A, et al. Serum urate is related to subclinical inflammation in asymptomatic hyperuricaemia. Rheumatology. 2021;60(1):371\u20139.","journal-title":"Rheumatology"},{"issue":"5","key":"1187_CR92","doi-asserted-by":"publisher","first-page":"030006052090295","DOI":"10.1177\/0300060520902950","volume":"48","author":"YY Huang","year":"2020","unstructured":"Huang YY, Ye Z, Gu SW, Jiang ZY, Zhao L. The efficacy and tolerability of febuxostat treatment in a cohort of Chinese Han population with history of gout. J Int Med Res. 2020;48(5):030006052090295.","journal-title":"J Int Med Res"},{"key":"1187_CR93","doi-asserted-by":"publisher","unstructured":"Hao G, Duan W, Sun J, Liu J, Peng B. Effects of febuxostat on serum cytokines IL\u20111, IL\u20114, IL\u20116, IL\u20118, TNF\u2011\u03b1 and COX\u20112. Exp Ther Med [Internet]. 2018 Nov 15 [cited 2024 Sep 27]; Available from: http:\/\/www.spandidos-publications.com\/https:\/\/doi.org\/10.3892\/etm.2018.6972","DOI":"10.3892\/etm.2018.6972"},{"issue":"6","key":"1187_CR94","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/s41584-022-00776-6","volume":"18","author":"G Schett","year":"2022","unstructured":"Schett G, Rahman P, Ritchlin C, McInnes IB, Elewaut D, Scher JU. Psoriatic arthritis from a mechanistic perspective. Nat Rev Rheumatol. 2022;18(6):311\u201325.","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"1187_CR95","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/j.1365-2133.2007.07986.x","volume":"157","author":"P Gisondi","year":"2007","unstructured":"Gisondi P, Tessari G, Conti A, Piaserico S, Schianchi S, Peserico A, et al. Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case?control study. Br J Dermatol. 2007;157(1):68\u201373.","journal-title":"Br J Dermatol"},{"issue":"17","key":"1187_CR96","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.2169\/internalmedicine.54.4310","volume":"54","author":"P Liu","year":"2015","unstructured":"Liu P, Wang H, Zhang F, Chen Y, Wang D, Wang Y. The Effects of Allopurinol on the Carotid Intima-media Thickness in Patients with Type 2 Diabetes and Asymptomatic Hyperuricemia: A Three-year Randomized Parallel-controlled Study. Intern Med. 2015;54(17):2129\u201337.","journal-title":"Intern Med"},{"issue":"6","key":"1187_CR97","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1053\/j.ajkd.2018.06.028","volume":"72","author":"K Kimura","year":"2018","unstructured":"Kimura K, Hosoya T, Uchida S, Inaba M, Makino H, Maruyama S, et al. Febuxostat therapy for patients with stage 3 CKD and Asymptomatic Hyperuricemia: A Randomized Trial. Am J Kidney Dis. 2018;72(6):798\u2013810.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"1187_CR98","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1053\/j.ajkd.2012.07.021","volume":"61","author":"DI Jalal","year":"2013","unstructured":"Jalal DI, Chonchol M, Chen W, Targher G. Uric Acid as a Target of Therapy in CKD. Am J Kidney Dis. 2013;61(1):134\u201346.","journal-title":"Am J Kidney Dis"},{"key":"1187_CR99","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2023-003428","volume":"9","author":"R Felten","year":"2023","unstructured":"Felten R, Widawski L, Spielmann L, et al. Impact of hyperuricaemia on patients with psoriatic arthritis treated with secukinumab in the FUTURE 2\u20135 and MAXIMISE studies. RMD Open. 2023;9: e003428.","journal-title":"RMD Open"},{"issue":"3","key":"1187_CR100","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.jbspin.2013.10.008","volume":"81","author":"D Arida","year":"2014","unstructured":"Arida D, Silva L, Skare TL. The hypouricemiant effect of leflunomide. Joint Bone Spine. 2014;81(3):273\u20134.","journal-title":"Joint Bone Spine"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-025-01187-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11926-025-01187-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-025-01187-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T19:02:29Z","timestamp":1770750149000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11926-025-01187-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,27]]},"references-count":100,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1187"],"URL":"https:\/\/doi.org\/10.1007\/s11926-025-01187-8","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,27]]},"assertion":[{"value":"5 March 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interest"}}],"article-number":"22"}}